KINTARA THERAPEUTICS

kintara-therapeutics-logo

Kintara Pharmaceuticals, Inc. engages in developing and commercializing cancer therapies in orphan and other cancer indications for the treatment of patients failing modern targeted or biologic therapy. The company’s principal product candidate includes VAL-083, a small-molecule chemotherapeutic agent, which is in clinical trials stage for the treatment of refractory glioblastoma multiforme, a form of brain cancer. Kintara Pharmaceuticals, Inc. also has a strategic collaboration with Guangxi Wuzhou Pharmaceutical Company for the development of VAL-083 used in treating chronic myelogenous leukemia and lung cancer. The company was founded in 2010 and is headquartered in Vancouver, Canada.
#SimilarOrganizations #People #Financial #Website #More

KINTARA THERAPEUTICS

Social Links:

facebook

Facebook

linkedin

Linkedin

twitter

Twitter

Industry:
Biotechnology Health Care Medical

Founded:
2010-01-01

Address:
Vancouver, British Columbia, Canada

Country:
Canada

Website Url:
http://www.kintara.com

Total Employee:
1+

Status:
Active

Contact:
604-629-5989

Email Addresses:
[email protected]

Total Funding:
105.83 M USD

Technology used in webpage:
SPF Amazon Google Apps For Business Cloudflare DNS Amazon Virginia Region Pound Sterling Japanese Yen Amazon Singapore Region Amazon Sydney Region


Similar Organizations

affimed-logo

Affimed

Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.

disarm-therapeutics-logo

Disarm Therapeutics

Disarm Therapeutics is a biotechnology company developing disease-modifying therapeutics for patients with axonal degeneration.


Current Advisors List

not_available_image

Tamara A. Seymour Member Board Of Directors and Audit Committee Chair @ Kintara Therapeutics
Board_member
2021-04-01

Current Employees Featured

jeffrey-bacha_image

Jeffrey Bacha
Jeffrey Bacha President & CEO/cofounder @ Kintara Therapeutics
President & CEO/cofounder
2021-03-01

scott-praill_image

Scott Praill
Scott Praill Chief Financial Officer @ Kintara Therapeutics
Chief Financial Officer

dennis-m-brown_image

Dennis M. Brown
Dennis M. Brown Chief Scientific Officer/cofounder & Director @ Kintara Therapeutics
Chief Scientific Officer/cofounder & Director

Founder


dennis-m-brown_image

Dennis M. Brown

jeffrey-bacha_image

Jeffrey Bacha

Stock Details


Company's stock symbol is NASDAQ:KTRA

Acquisitions List

Date Company Article Price
2020-06-10 Adgero Biopharmaceuticals Adgero Biopharmaceuticals acquired by Kintara Therapeutics N/A

Investors List

lincoln-park-capital-fund_image

Lincoln Park Capital Fund

Lincoln Park Capital Fund investment in Post-IPO Equity - Kintara Therapeutics

luxembourg-national-research-fund_image

Luxembourg National Research Fund

Luxembourg National Research Fund investment in Grant - Kintara Therapeutics

sternaegis-ventures_image

SternAegis

SternAegis investment in Post-IPO Equity - Kintara Therapeutics

Official Site Inspections

http://www.kintara.com Semrush global rank: 6.44 M Semrush visits lastest month: 1.01 K

  • Host name: ec2-174-129-30-187.compute-1.amazonaws.com
  • IP address: 174.129.30.187
  • Location: Ashburn United States
  • Latitude: 39.0481
  • Longitude: -77.4728
  • Metro Code: 511
  • Timezone: America/New_York
  • Postal: 20149

Loading ...

More informations about "Kintara Therapeutics" on Search Engine

dfkcompany.com © 2022. All rights reserved